Skip to main
  1. Stocks
  2. Acadia Healthcare
  3. Forecast
ACHC

Acadia Healthcare (ACHC) Stock Forecast & Price Target

Acadia Healthcare (ACHC) Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 42%
Buy 17%
Hold 33%
Sell 8%
Strong Sell 0%

Bulls say

Acadia Healthcare Co is viewed positively because its acute inpatient psychiatric facilities continue to drive the majority of U.S. revenue, while same-facility patient days rose 1.1% and revenue per patient day increased 4.0%, showing healthy demand and pricing power. Management also raised 2026 adjusted EBITDA guidance to $615 million-$625 million after 3Q26 EBITDA of $176 million beat expectations, with new facility cohorts improving faster than expected as licensing, accreditation, and payor contracting progress. The core long-term thesis is that roughly $200 million of incremental EBITDA opportunity can be unlocked as startup losses fall from about $45 million to $10 million and the 2023-26 cohorts move beyond breakeven, supporting stronger cash flow and margin expansion.

Bears say

Acadia Healthcare Co is viewed negatively because its 2027 EBITDA bridge appears dependent on an unsized and incomplete set of tailwinds, while management gave limited visibility on PLGL, the NY Medicaid/PA backfill, CTC revenue, investigation costs, and more than $20M of Florida and Ohio DPP under review. The risk profile is further weakened by Medicaid funding and reimbursement pressure, slower-than-expected ramp of beds added between 2023 and 2026, and behavioral media/regulatory scrutiny that could intensify and pressure both sentiment and demand. With EBITDA headwinds threatening cash generation and flexibility, the business may struggle to convert its roughly $672M starting point into durable growth if cost inflation, labor tightness, and reimbursement issues persist.

Acadia Healthcare (ACHC) has been analyzed by 12 analysts, with a consensus rating of Buy. 42% of analysts recommend a Strong Buy, 17% recommend Buy, 33% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Acadia Healthcare (ACHC) Analyst Forecast & Price Prediction

Get the latest Acadia Healthcare (ACHC) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Acadia Healthcare (ACHC)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Acadia Healthcare (ACHC) Forecast

Analysts have given Acadia Healthcare (ACHC) a Buy based on their latest research and market trends.

According to 12 analysts, Acadia Healthcare (ACHC) has a Buy consensus rating as of Nov 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $32, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $32, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Acadia Healthcare (ACHC)


Acadia Healthcare (ACHC) Analyst Forecast & Price Prediction

Get the latest Acadia Healthcare (ACHC) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Acadia Healthcare (ACHC)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover ACHC stock data and trends